New twice-yearly HIV injection set to boost medication adherence in Zimbabwe
Health authorities have said the long-acting antiretroviral drug, Lenacapavir (LEN) is expected dramatically improve patient compliance by removing the need for daily pills.
By Nizbert Moyo
2h ago
Zim’s Lenacapavir lottery: A tale of two worlds
IN the bustling streets of Epworth, 18-year-old Tadiwanashe Moyo, clutches a tattered piece of paper, her eyes scanning it with a mixture of hope and trepidation.
By Tonderayi Matonho
Feb. 27, 2026
Epworth welcomes new HIV prevention drug
“We gather here to launch Lenacapavir, a long-term injectable option for HIV prevention, and to show our commitment to protecting life and ending Aids as a public health threat.”.
By Jairos Nhakano
Feb. 22, 2026
'Miracle' HIV shot rollout in Zimbabwe sparks debate
Lenacapavir, the first twice-yearly HIV prophylactic in the world, is set to be rolled out in Zimbabwe, one of 10 countries selected for the initial rollout of the injectable drug.
By Staff Reporter
Oct. 20, 2025
Life-saving Aids jab boost for Zim
IN a major boost to the fight against HIV and Aids, Zimbabwe has been selected as one of the 10 countries globally to roll out lenacapavir
By Sydney Kawadza
Sep. 24, 2025
